User contributions for Lazy

13 June 2024

• 20:4820:48, 13 June 2024 diff hist +48‎ Category:Highly Useful Treatments ‎No edit summary
• 20:4720:47, 13 June 2024 diff hist −22‎ Category:Highly Useful Treatments ‎ →‎Highly Useful Treatments
• 20:4520:45, 13 June 2024 diff hist −4‎ Anlotinib ‎No edit summary
• 20:4420:44, 13 June 2024 diff hist +2,897‎ N Anlotinib ‎ Created page with "{{TreatmentInfo |drug_name=Anlotinib |FDA_approval=Under investigation; not yet FDA-approved |used_for=Various cancers including Non-Small Cell Lung Cancer (NSCLC), Soft Tissue Sarcoma, and Renal Cell Carcinoma; being investigated for Glioblastoma Multiforme (GBM) |clinical_trial_phase=Phase 2 and 3 (for different cancers); early-stage trials for GBM |common_side_effects=Hypertension, fatigue, hand-foot syndrome, diarrhea, proteinuria, thyroid dysfunction |OS_without=Med..."
• 20:2220:22, 13 June 2024 diff hist +83,438‎ Main Page ‎No edit summary

29 May 2024

• 21:0221:02, 29 May 2024 diff hist +324‎ N Plotly ‎ Created page with "== Glioblastoma Treatments == <div id="categories"></div> <div id="plot"></div> <!-- Include Plotly script --> <script src="https://cdn.plot.ly/plotly-latest.min.js"></script> <!-- Load the page-specific JavaScript --> <script src="/index.php?title=MediaWiki:InteractivePlot.js&action=raw&ctype=text/javascript"></script>" current
• 21:0021:00, 29 May 2024 diff hist +2,719‎ N MediaWiki:InteractivePlot.js ‎ Created page with "$(document).ready(function() { // Fetch the JSON data from the query result page fetch('https://glioblastomatreatments.wiki/index.php?title=Special:Ask/-5B-5BHas-20Usefulness-20Rating::%2B-5D-5D/-3FHas-20treatment-20name%3DTreatment-20Name/-3FHas-20Usefulness-20Rating%3DUsefulness-20Rating/-3FHas-20Toxicity-20Level%3DToxicity-20Level/-3FCategory/mainlabel%3D-2D/limit%3D100/offset%3D0/format%3Djson') .then(response => response.json()) .then(data => {..." current
• 20:5520:55, 29 May 2024 diff hist +2,834‎ N Plot ‎ Created page with "<div id="categories"></div> <div id="plot"></div> <script src="https://cdn.plot.ly/plotly-latest.min.js"></script> <script> // Fetch the JSON data from the query result page fetch('https://glioblastomatreatments.wiki/index.php?title=Special:Ask/-5B-5BHas-20Usefulness-20Rating::%2B-5D-5D/-3FHas-20treatment-20name%3DTreatment-20Name/-3FHas-20Usefulness-20Rating%3DUsefulness-20Rating/-3FHas-20Toxicity-20Level%3DToxicity-20Level/-3FCategory/mainlabel%3D-2D/limit%3D1..." current
• 20:4820:48, 29 May 2024 diff hist −1‎ Treatments Plot ‎No edit summary current
• 20:4820:48, 29 May 2024 diff hist +15‎ Treatments Plot ‎No edit summary
• 20:4720:47, 29 May 2024 diff hist +4‎ Treatments Plot ‎No edit summary
• 20:4720:47, 29 May 2024 diff hist −5‎ Treatments Plot ‎No edit summary
• 20:4720:47, 29 May 2024 diff hist 0‎ Treatments Plot ‎No edit summary
• 20:4620:46, 29 May 2024 diff hist −15‎ Treatments Plot ‎No edit summary
• 20:4520:45, 29 May 2024 diff hist 0‎ Treatments Plot ‎No edit summary
• 20:4520:45, 29 May 2024 diff hist 0‎ Treatments Plot ‎No edit summary
• 20:4520:45, 29 May 2024 diff hist −32‎ Treatments Plot ‎No edit summary
• 20:4420:44, 29 May 2024 diff hist +29‎ Treatments Plot ‎No edit summary
• 20:4420:44, 29 May 2024 diff hist +20‎ Treatments Plot ‎No edit summary
• 20:4320:43, 29 May 2024 diff hist +33‎ Treatments Plot ‎No edit summary Tag: Manual revert
• 20:4220:42, 29 May 2024 diff hist −91‎ Treatments Plot ‎No edit summary Tag: Reverted
• 20:4120:41, 29 May 2024 diff hist +92‎ Treatments Plot ‎No edit summary Tag: Reverted
• 17:2017:20, 29 May 2024 diff hist −34‎ Treatments Plot ‎No edit summary Tag: Reverted
• 17:1617:16, 29 May 2024 diff hist +59‎ Treatments Plot ‎No edit summary
• 17:1617:16, 29 May 2024 diff hist −23‎ Treatments Plot ‎No edit summary
• 17:1517:15, 29 May 2024 diff hist −56‎ Treatments Plot ‎No edit summary
• 17:1317:13, 29 May 2024 diff hist +21‎ Treatments Plot ‎No edit summary
• 17:1117:11, 29 May 2024 diff hist −17‎ Treatments Plot ‎No edit summary
• 17:1017:10, 29 May 2024 diff hist −14‎ Treatments Plot ‎No edit summary
• 17:0917:09, 29 May 2024 diff hist −2,314‎ Treatments Plot ‎ →‎Glioblastoma Treatments Tag: Replaced
• 17:0017:00, 29 May 2024 diff hist +2,530‎ N Treatments Plot ‎ Created page with "== Glioblastoma Treatments == <div id="categories"></div> <div id="plot"></div> <script src="https://cdn.plot.ly/plotly-latest.min.js"></script> <script> // Fetch the JSON data from the query result fetch('/index.php?title=Special:Ask&format=json&q=Category:Treatments|%3FHas+treatment+name=Treatment|%3FHas+Effectiveness=Effectiveness|%3FHas+Toxicity=Toxicity|%3FHas+Category=Category|format=json|link=none|headers=hide|mainlabel=-') .then(response => resp..."

27 May 2024

• 17:1717:17, 27 May 2024 diff hist +101‎ Main Page ‎ →‎Glioblastoma

17 May 2024

• 20:1220:12, 17 May 2024 diff hist +3,163‎ N Metronomic low dose temozolomide (TMZ) ‎ Created page with "{{TreatmentInfo |drug_name=Metronomic Low-Dose Temozolomide (TMZ) |FDA_approval=FDA-approved for glioblastoma but standard metronomic dosing is still under investigation |used_for=Glioblastoma Multiforme (GBM), recurrent GBM |clinical_trial_phase=Phase II and III for metronomic dosing schedules |common_side_effects=Nausea, vomiting, fatigue, myelosuppression, lymphopenia |OS_without=Median overall survival for GBM is typically 15-17 months from diagnosis |OS_with=Studies..."
• 10:0510:05, 17 May 2024 diff hist +356‎ Hyperthermia ‎No edit summary
• 10:0310:03, 17 May 2024 diff hist +1,629‎ N Hyperthermia ‎ Created page with "{{TreatmentInfo |drug_name=Hyperthermia |FDA_approval=Investigational |used_for=Glioblastoma Multiforme (GBM) |clinical_trial_phase=Phase I/II |common_side_effects=Localized discomfort, potential damage to surrounding healthy tissue |OS_without=Standard progression statistics for GBM |OS_with=Extended survival reported in some clinical trials |PFS_without=Standard progression statistics for GBM |PFS_with=Improved progression-free survival in combination with other treatm..."

15 May 2024

• 16:1016:10, 15 May 2024 diff hist −1‎ Main Page ‎No edit summary
• 16:0916:09, 15 May 2024 diff hist +166‎ Main Page ‎ →‎Tumor-associated antigen vaccines
• 16:0216:02, 15 May 2024 diff hist +8‎ Chronotherapy ‎No edit summary
• 16:0116:01, 15 May 2024 diff hist +1,583‎ N Chronotherapy ‎ Created page with "{{TreatmentInfo |drug_name=Chronotherapy with Temozolomide (TMZ) |FDA_approval=Yes (as part of standard glioblastoma treatment) |used_for=Glioblastoma Multiforme (GBM) |clinical_trial_phase=Research ongoing |common_side_effects=Increased side effects when administered in the morning; however, these are generally manageable with other therapies. |OS_without=Around 19.5 months for patients with MGMT methylated tumors. |OS_with=Up to 17 months for general cases, and up to 2..."

28 April 2024

• 11:0111:01, 28 April 2024 diff hist −4‎ Main Page ‎ →‎Alternative Therapies Targeting GSCs
• 11:0011:00, 28 April 2024 diff hist −14‎ Main Page ‎ →‎Alternative Therapies Targeting GSCs
• 10:5710:57, 28 April 2024 diff hist +3,025‎ N Parthenolide ‎ Created page with "{{TreatmentInfo |drug_name=Parthenolide |FDA_approval=No (Used primarily in research settings; not FDA-approved for cancer treatment) |used_for=Investigational use in cancer treatment, specifically for its effects on glioblastoma and glioma stem cells |clinical_trial_phase=Preclinical studies |clinical_trial_explanation=Parthenolide is being studied for its potential anti-cancer properties in glioblastoma, particularly focusing on its ability to target and kill glioma st..."
• 10:5510:55, 28 April 2024 diff hist −21‎ Metformin ‎No edit summary
• 10:5310:53, 28 April 2024 diff hist +2,886‎ N Metformin ‎ Created page with "{{TreatmentInfo |drug_name=Metformin |FDA_approval=Yes (Approved for type 2 diabetes; not FDA-approved for cancer treatment) |used_for=Investigational use in cancer treatment, specifically studied for effects on glioblastoma and glioma stem cells |clinical_trial_phase=Preclinical studies and some clinical trials |clinical_trial_explanation=Metformin is under investigation for its potential anti-cancer properties in glioblastoma, particularly its effects on glioma stem ce..."
• 10:4910:49, 28 April 2024 diff hist +27‎ Sulforaphane ‎No edit summary
• 10:4710:47, 28 April 2024 diff hist +2,892‎ N Sulforaphane ‎ Created page with "{{TreatmentInfo |drug_name=Sulforaphane |FDA_approval=No (Used as a dietary supplement; not FDA-approved for cancer treatment) |used_for=Investigational use in cancer treatment, particularly in preclinical studies focusing on glioblastoma |clinical_trial_phase=Preclinical studies |clinical_trial_explanation=Sulforaphane is being studied in preclinical models for its potential as an anti-cancer agent against glioblastoma. Research focuses on its ability to inhibit histone..."
• 10:4610:46, 28 April 2024 diff hist +3,405‎ N Resveratrol ‎ Created page with "{{TreatmentInfo |drug_name=Resveratrol |FDA_approval=No (Used as a dietary supplement; not FDA-approved for cancer treatment) |used_for=Investigational use in cancer treatment and prevention; also studied for cardiovascular benefits and anti-aging properties |clinical_trial_phase=Preclinical studies and early clinical trials |clinical_trial_explanation=Resveratrol is being studied for its potential anti-cancer properties in preclinical and early clinical trials, focusing..."
• 10:4310:43, 28 April 2024 diff hist +2,257‎ Main Page ‎ →‎Cancer Stem Cells (CSCs) in Glioblastoma: Challenges with Standard of Care (SOC)
• 10:3710:37, 28 April 2024 diff hist +32‎ Main Page ‎ →‎Conclusion
• 10:3510:35, 28 April 2024 diff hist +79‎ Main Page ‎ →‎Conclusion